Mel-Mont Medical Inc

Mel-Mont Medical Inc is a clinical diagnostics and molecular technology company specializing in HPV-related cancer detection and prevention. The company develops patented, non-invasive self-sampling medical devices coupled with proprietary comprehensive molecular testing platforms for early identification of high-risk human papillomavirus (HR-HPV) infections. The company operates three primary product divisions: (1) Medical Devices—user-friendly, patented devices for HPV-related cancer prevention; (2) In Vitro Diagnostics (PreTect division)—ISO 13485-certified molecular assays for nucleic acid amplification and HPV-mRNA testing with proprietary laboratory services; (3) Sample Preparation Reagents—molecular testing reagents and transport media for sample handling. Mel-Mont Medical maintains a rigorous R&D pipeline following a six-stage development methodology: concept identification, usage characterization, design and development, pilot production and validation, regulatory prelaunch monitoring, and market launch with post-market surveillance. The company conducts preclinical and clinical trials to validate devices before market introduction and emphasizes clinically proven molecular biology technologies. Products are manufactured in compliance with applicable standards. The company serves international markets including the United States, Mexico, Spain, Norway, and Colombia, with distribution and manufacturing partnerships in select regions.